Jun-bao Liua,
Dan Chenb,
Hai-xia Liuc,
Huan-huan Shabd,
Dan Songe,
Ting-ting Baof,
Jian-wei Lug and
Chen Yu*f
aTraditional Chinese Medicine Department, People’s Hospital of Henan Province, People’s Hospital of Zhengzhou University, Zhengzhou, Henan 450003, China
bResearch Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiang Su 210000, China
cEmergency Department, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiang Su 210017, China
dThe Forth Clinical School of Nanjing Medical University, Nanjing, Jiang Su 210000, China
eDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiang Su 210000, China
fDepartment of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiang Su 210000, China. E-mail: 41186709@qq.com
gDepartment of Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiang Su 210000, China
First published on 22nd November 2018
Correction for ‘A microRNA-4516 inhibitor sensitizes chemo-resistant gastric cancer cells to chemotherapy by upregulating ING4’ by Jun-bao Liu et al., RSC Adv., 2018, 8, 37795–37803.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2018 |